MicroRNA-9 suppresses uveal melanoma cell migration and invasion through the NF-κB1 pathway

Oncology Reports

Volumn 28, Issue 3, 2012, Pages 961-968

  Liu, Nannan ^a,b   Sun, Qingmin ^a   Chen, Jie ^c   Li, Jiaqi ^a   Zeng, Ying ^a   Zhai, Sulan ^a   Li, Ping ^a   Wang, Bin ^a   Wang, Xuerong ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Invasion; Migration; MiR 9; NF B1; Uveal melanoma

Indexed keywords

GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA 9; VASCULOTROPIN A;

3' UNTRANSLATED REGION; ARTICLE; CANCER INHIBITION; CANCER INVASION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; UVEA MELANOMA;

BASE SEQUENCE; CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MELANOMA; MICRORNAS; NEOPLASM INVASIVENESS; NF-KAPPA B P50 SUBUNIT; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UVEAL NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84865336597     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1905     Document Type: Article

References (33)

1. Seftor EA, Meltzer PS, Kirschmann DA, Pe'er J, Maniotis AJ, Trent JM, Folberg R and Hendrix MJ: Molecular determinants of human uveal melanoma invasion and metastasis. Clin Exp Metastasis 19: 233-246, 2002.
2. Triozzi PL, Eng C and Singh AD: Targeted therapy for uveal melanoma. Cancer Treat Rev 34: 247-258, 2008.
3. Singh AD, Turell ME and Topham AK: Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology 118: 1881-1885, 2011.
4. Sun Q, Cong R, Yan H, Gu H, Zeng Y, Liu N, Chen J and Wang B: Genistein inhibits growth of human uveal melanoma cells and affects microRNA-27a and target gene expression. Oncol Rep 22: 563-567, 2009.
5. Nicoloso MS, Spizzo R, Shimizu M, Rossi S and Calin GA: MicroRNAs - the micro steering wheel of tumour metastases. Nat Rev Cancer 9: 293-302, 2009.
6. Tsai KW, Liao YL, Wu CW, Hu LY, Li SC, Chan WC, et al: Aberrant hypermethylation of miR-9 genes in gastric cancer. Epigenetics 6: 1189-1197, 2011.
7. Wan HY, Guo LM, Liu T, Liu M, Li X and Tang H: Regulation of the transcription factor NF-kappaB1 by microRNA-9 in human gastric adenocarcinoma. Mol Cancer 9: 16, 2010.
8. Hu X, Schwarz JK, Lewis JS, Huettner PC, Rader JS, Deasy JO, et al: A microRNA expression signature for cervical cancer prognosis, Cancer Res 70: 1441-1448, 2010.
9. Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, et al: miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 12: 247-256, 2010.
10. Zhu L, Chen H, Zhou D, Li D, Bai R, Zheng S and Ge W: MicroRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility. Med Oncol 29: 1037-1043, 2012.
11. Liu S, Kumar SM, Lu H, Liu A, Yang R, Pushparajan A, Guo W and Xu X: MicroRNA-9 up-regulates E-cadherin through inhibition of NF-κB1-Snail1 pathway in melanoma. J Pathol 226: 61-72, 2012.
12. Amiri KI and Richmond A: Role of nuclear factor-kappa B in melanoma. Cancer Metastasis Rev 24: 301-313, 2005.
13. Pereira SG and Oakley F: Nuclear factor-kappaB1: regulation and function. Int J Biochem Cell Biol 40: 1425-1430, 2008.
14. Vaisanen A, Kallioinen M, von Dickhoff K, Laatikainen L, Hoyhtya M and Turpeenniemi-Hujanen T: Matrix metalloproteinase-2 (MMP-2) immunoreactive protein - a new prognostic marker in uveal melanoma? J Pathol 188: 56-62, 1999.
15. Sahin A, Kiratli H, Soylemezoglu F, Tezel GG, Bilgic S and Saracbasi O: Expression of vascular endothelial growth factor-A, matrix metalloproteinase-9, and extravascular matrix patterns and their correlations with clinicopathologic parameters in posterior uveal melanomas. Jpn J Ophthalmol 51: 325-331, 2007.
16. Hendrix MJ, Seftor EA, Meltzer PS, Gardner LM, Hess AR, et al: Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry. Proc Natl Acad Sci USA 98: 8018-8023, 2001.
17. Dror R, Lederman M, Umezawa K, Barak V, Pe'er J and Chowers I: Characterizing the involvement of the nuclear factor-kappa B (NF kappa B) transcription factor in uveal melanoma. Invest Ophthalmol Vis Sci 51: 1811-1816, 2010.
18. Yan C and Boyd DD: Regulation of matrix metalloproteinase gene expression. J Cell Physiol 211: 19-26, 2007.
19. Karst AM, Gao K, Nelson CC and Li G: Nuclear factor kappa B subunit p50 promotes melanoma angiogenesis by upregulating interleukin-6 expression. Int J Cancer 124: 494-501, 2009.
20. Yang C and Wei W: The miRNA expression profile of the uveal melanoma. Sci China Life Sci 54: 351-358, 2011.
21. Yan D, Zhou X, Chen X, Hu DN, Dong XD, Wang J, et al: MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met. Invest Ophthalmol Vis Sci 50: 1559-1565, 2009.
22. Worley LA, Long MD, Onken MD and Harbour JW: MicroRNAs associated with metastasis in uveal melanoma identified by multiplexed microarray profiling. Melanoma Res 18: 184-190, 2008.
23. Bandres E, Agirre X, Bitarte N, Ramirez N, Zarate R, Roman-Gomez J, et al: Epigenetic regulation of microRNA expression in colorectal cancer. Int J Cancer 125: 2737-2743, 2009.
24. Omura N, Li CP, Li A, Hong SM, Walter K, Jimeno A, et al: Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma. Cancer Biol Ther 7: 1146-1156, 2008.
25. Ferretti E, De Smaele E, Po A, Di Marcotullio L, Tosi E, Espinola MS, et al: MicroRNA profiling in human medulloblastoma. Int J Cancer 124: 568-577, 2009.
26. Laios A, O'Toole S, Flavin R, Martin C, Kelly L, Ring M, et al: Potential role of miR-9 and miR-223 in recurrent ovarian cancer. Mol Cancer 7: 35, 2008.
27. Hildebrandt MA, Gu J, Lin J, Ye Y, Tan W, Tamboli P, et al: Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma. Oncogene 29: 5724-5728, 2010.
28. Myatt SS, Wang J, Monteiro LJ, Christian M, Ho KK, Fusi L, et al: Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer. Cancer Res 70: 367-377, 2010.
29. Rotkrua P, Akiyama Y, Hashimoto Y, Otsubo T and Yuasa Y: MiR-9 downregulates CDX2 expression in gastric cancer cells. Int J Cancer 129: 2611-2620, 2011.
30. Wöll E, Bedikian A and Legha SS: Uveal melanoma: natural history and treatment options for metastatic disease. Melanoma Res 9: 575-581, 1999.
31. Gao K, Dai DL, Martinka M and Li G: Prognostic significance of nuclear factor-kappaB p105/p50 in human melanoma and its role in cell migration. Cancer Res 66: 8382-8388, 2006.
32. El-Shabrawi Y, Ardjomand N and Radner H: MMP-9 is predominantly expressed in epithelioid and not spindle cell uveal melanoma. J Pathol 194: 201-206, 2001.
33. Crosby MB, Yang H, Gao W, Zhang L and Grossniklaus HE: Serum vascular endothelial growth factor (VEGF) levels correlate with number and location of micrometastases in a murine model of uveal melanoma, Br J Ophthalmol 95: 112-117, 2011.